These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma. Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase. Burgess GS; Williamson EA; Cripe LD; Litz-Jackson S; Bhatt JA; Stanley K; Stewart MJ; Kraft AS; Nakshatri H; Boswell HS Blood; 1998 Oct; 92(7):2450-60. PubMed ID: 9746785 [TBL] [Abstract][Full Text] [Related]
13. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Pan C; Olsen JV; Daub H; Mann M Mol Cell Proteomics; 2009 Dec; 8(12):2796-808. PubMed ID: 19651622 [TBL] [Abstract][Full Text] [Related]
14. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. Bauer J; Köhler N; Maringer Y; Bucher P; Bilich T; Zwick M; Dicks S; Nelde A; Dubbelaar M; Scheid J; Wacker M; Heitmann JS; Schroeder S; Rieth J; Denk M; Richter M; Klein R; Bonzheim I; Luibrand J; Holzer U; Ebinger M; Brecht IB; Bitzer M; Boerries M; Feucht J; Salih HR; Rammensee HG; Hailfinger S; Walz JS Nat Commun; 2022 Oct; 13(1):6401. PubMed ID: 36302754 [TBL] [Abstract][Full Text] [Related]
16. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. Carlesso N; Frank DA; Griffin JD J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285 [TBL] [Abstract][Full Text] [Related]
17. Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Shirani M; Levin S; Shebl B; Requena D; Finkelstein TM; Johnson DS; Ng D; Lalazar G; Heissel S; Hojrup P; Molina H; de Jong YP; Rice CM; Singhi AD; Torbenson MS; Coffino P; Lyons B; Simon SM Cancer Res; 2024 Aug; 84(16):2626-2644. PubMed ID: 38888469 [TBL] [Abstract][Full Text] [Related]
18. Human transcription factor and protein kinase gene fusions in human cancer. Salokas K; Weldatsadik RG; Varjosalo M Sci Rep; 2020 Aug; 10(1):14169. PubMed ID: 32843691 [TBL] [Abstract][Full Text] [Related]
19. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells. Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085 [TBL] [Abstract][Full Text] [Related]